Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BIOSENIC S.A. logo — New solutions for autoimmune, inflammatory and bone diseases...

BIOSENIC S.A.

New solutions for autoimmune, inflammatory and bone diseases.

Founded 2006 Belgium Belgium 16 employees Post Ipo Equity Total: $16.30M Biopharma, Biotechnology

General Information

Company Name BIOSENIC S.A.
Founded Year 2006
Location Belgium Belgium +1
Employees 16
Industries Biopharma, Biotechnology
Funding Stage Post Ipo Equity
Social

Get notified when BIOSENIC S.A. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BIOSENIC S.A.

BioSenic S.A. is a biopharmaceutical and biotechnology startup founded in 2022 in Belgium. The company is dedicated to providing new solutions for autoimmune, inflammatory, and bone diseases. BioSenic aims to address unmet medical needs within the areas of immunity, auto-immune diseases, and organ repair. The startup has attracted a €500.00KPost-IPO Equity investment as of 02 February 2024. With its focus on critical medical needs, BioSenic presents potential value for investors looking to support innovative solutions in the biopharmaceutical and biotechnology industries.

Taxonomy: autoimmune diseases, inflammation, immunology, medical innovation, organ repair, biomedical technology

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 02 Feb 2024
Post-IPO Debt •••••• - 08 Jan 2024
Post-IPO Debt •••••• 1 •••• •••• 14 Sep 2023

BIOSENIC S.A. Alternatives & Competitors

BIOSENIC S.A. vs
Office of the Secretary of the Navy
Office of the Secretary of the Navy United States

Responsible for acquisition, auditing, financial and information management, legislative affairs, an...

48 employees
BIOSENIC S.A. vs
CARMIN
CARMIN Romania

advertising and stuff The quick brown fox jumps over the lazy dog The quick brown fox jumps over t...

14 employees
BIOSENIC S.A. vs
The National Bank of Kazakhstan
The National Bank of Kazakhstan Kazakhstan

About the National Bank of the Republic of Kazakhstan The Republic of Kazakhstan has a two-tier ban...

280 employees
Finance, Financial Services

FAQ About BIOSENIC S.A.

New solutions for autoimmune, inflammatory and bone diseases.
BIOSENIC S.A. was founded in 2006.
BIOSENIC S.A. is headquartered in Belgium.
BIOSENIC S.A. operates in the following industries: Biopharma, Biotechnology.
BIOSENIC S.A. has approximately 16 employees.
BIOSENIC S.A. has completed 3 funding rounds, raising a total of $16.30M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to BIOSENIC S.A. include Office of the Secretary of the Navy, CARMIN, The National Bank of Kazakhstan, FUCT™, Medical Edge Communications. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BIOSENIC S.A. and Office of the Secretary of the Navy are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BIOSENIC S.A. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes